Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anemia × continuous erythropoietin receptor activator × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2 Thoracic 1

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Anemia 1

Interventions

Epoetin Alfa 3 Darbepoetin alfa 3 pegfilgrastim 1 continuous erythropoietin receptor activator 1 Docetaxel 1 Cisplatin 1 ACE-011 1 2,2'-dithiodiethanesulfonic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00072059 2013-07-18

Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed

Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡